Labshake search
Citations for Tocris :
1 - 50 of 1263 citations for 1 3 Methoxyphenyl 6 7 dimethyl 6 azoniabicyclo 3.2.1 octane bromide since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Neuroscience 2020Quote: ... 1-[2-(4-Methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride (SKF-96365; 1147, Tocris) in ddH20 ...
-
bioRxiv - Cell Biology 2023Quote: ... Neurosensor 510 (7-(Diethylamino)-4-(4-methoxyphenyl)-2-oxo-2H-1-benzopyran-3-carboxaldehyde) was purchased from (Tocris).
-
bioRxiv - Microbiology 2024Quote: ... along with 10 µM GSK-3 α and β inhibitor 1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea (Tocris) as previously described20 ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris) and mounted in modified rose chambers ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris). For monastrol arrest and release experiments ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris).
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2024Quote: ... 5 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX, AMPA receptor antagonist, Tocris, 1044) and 5 μM (RS)-3-(2-Carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP ...
-
bioRxiv - Cell Biology 2021Quote: ... 20 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris Bioscience) and 50 μM D ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 µM, Tocris, UK), DL-2-Amino-5-phosphonopentanoic acid (DL-AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX disodium salt, Catalog #1045, Tocris), (R)-Baclofen (Catalog #0796 ...
-
bioRxiv - Cell Biology 2021Quote: ... at 50 μM and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris) at 20 μM in the bath solution to block excitatory synaptic transmission ...
-
bioRxiv - Neuroscience 2020Quote: ... and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) were purchased from TOCRIS Bioscience (Cat ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, Tocris, Minneapolis, MN, USA) and d-(−)-2-amino-5-phosphonopentanoic acid (APV ...
-
bioRxiv - Neuroscience 2022Quote: ... 2,3-dioxo-6-nitro-7-sulfamoyl-benzoquinoxaline (NBQX, 25 μM; Tocris #0373), D-2-Amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Immunology 2022Quote: ... BV-6 and Birinapant (from SelleckChem) and (5Z)-7-Oxozeaenol (from Tocris) were dissolved in DMSO at 10 mM and added to achieve the final concentrations indicated in figure legends ...
-
bioRxiv - Neuroscience 2024Quote: ... 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris,Bristol, UK), 20 µM L-(+)-2-amino-4-phosphonobutyric acid (L-AP4 ...
-
bioRxiv - Neuroscience 2020Quote: ... The GAT1 blocker NO-711 [(1,2,5,6-tetrahydro-1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-3-pyridinecarboxylic acid hydrochloride] and GAT3 blocker SNAP-5114 [1-[2-[tris(4-methoxyphenyl)methoxy]ethyl]-(S)-3-piperidinecarboxylic acid] were purchased from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2020Quote: ... 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX, Tocris) and N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide (IEM-1460 ...
-
bioRxiv - Neuroscience 2020Quote: NBQX (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) from Tocris CGP-55845 ((2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydro xypropyl](phenylmethyl)phosphinic acid hydrochloride ...
-
bioRxiv - Neuroscience 2023Quote: ... Inhibitor cocktail containing 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris, 10 μM), (2R)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris #I-440-01M) and mounted in modified rose chambers ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (Tocris). Each epoch of the BQA experiment contains a stable segment of 28 up to 42 unitary IPSCs (mean 32.75 ± 4.15) ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (Tocris), 10 μM 4-(N-Ethyl-N-phenylamino)-1,2 dimethyl-6-(methylamino ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX) were purchased from Tocris. 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP ...
-
bioRxiv - Cell Biology 2024Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX 20 µM, Tocris). After the imaging session ...
-
bioRxiv - Developmental Biology 2024Quote: ... embryos were treated with BIO (6-bromoindirubin-3’-oxime) (TOCRIS Bioscience), a small molecule inhibitor of glycogen synthase kinase-3 (Sato et al. ...
-
bioRxiv - Neuroscience 2024Quote: ... VU0360172 [N-cyclobutyl-6-(2-(3-fluorophenyl)ethynyl) pyridine-3-carboxamide] was purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX disodium salt; Cat. No. 1045, Tocris, UK), DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris Bioscience, Briston, UK) and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Physiology 2022Quote: ... 50U penicillin and 50U streptomycin) with 3-6 μM CHIR (4423, Tocris). 2 days after initial CHIR addition ...
-
bioRxiv - Neuroscience 2024Quote: 6-hydroxydopamine (Tocris) injections were performed in WT mice at 8-9 weeks of age ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2024Quote: AMPA/kainate glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 20 μM, Tocris Bioscience) and NMDA glutamate receptor antagonist (RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid ((RS)-CPP ...
-
bioRxiv - Microbiology 2024Quote: To investigate the impact of gallein (3’,4’,5’,6’-Tetrahydroxyspiro[isobenzofuran-1(3H),9’- (9H)xanthen]-3-one) (Cat#3090, Tocris, Minneapolis, MN) and/or INH on Mtb growth ...
-
bioRxiv - Neuroscience 2020Quote: ... 0.9% w/v) and 6-OHDA HCl powder (6-hydroxydopamine hydrochloride from Sigma or 6-OHDA hydrobromide from Tocris) was then dissolved to produce a final 6-OHDA concentration of 4.44 mg/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... Calcium-like peptide 2 (CALP2) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) were obtained from Tocris (Minneapolis, MN). CaM kinase II and calcineurin inhibitors ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2022Quote: ... 3,5-dichloro-N-[[(1α,5α,6-exo,6α)-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]-benzamide-hydrochloride (ML218 or ml) was purchased from TOCRIS and initially dissolved at 50 mM in DMSO ...
-
bioRxiv - Developmental Biology 2021Quote: ... CHIR99021 (6 μM; Tocris), FGF2 (20 ng/mL ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.